Therapy News and Research

RSS

Mitochondrial alternative oxidase from sea-squirt shows potential to fight against sepsis

Mitochondrial alternative oxidase from a sea-squirt works as a safety valve for stressed mitochondria. This property enables it to stop the runaway inflammatory process that leads to multiple organ failure and eventual death in bacterial sepsis.

23 Sep 2016

Researchers receive grant to help develop stem cell therapy for glaucoma

Researchers from the University's Institute of Ageing and Chronic Disease have been awarded a pump-priming grant to help develop a stem cell therapy for glaucoma.

23 Sep 2016

Precision medicine trial shows analysing person's DNA improves treatment options for cancer patients

A clinical trial for types of advanced cancer is the first of its kind to show that precision medicine - or tailoring treatment for individual people - can slow down the time it takes for a tumour to grow back, according to research presented at the Molecular Analysis for Personalised Therapy (MAP) conference, today (Friday).

23 Sep 2016

Review highlights anxiety may lead to serious health consequences in dialysis patients

A new review looks at the potential effects of anxiety on a vulnerable patient population: individuals undergoing hemodialysis for the treatment of kidney failure.

23 Sep 2016

Magnetic bacteria can be promising vehicle for efficiently delivering tumor-fighting drugs

Researchers funded in part by the National Institute of Biomedical Imaging and Bioengineering have recently shown that magnetic bacteria are a promising vehicle for more efficiently delivering tumor-fighting drugs. They reported their results in the August 2016 issue of Nature Nanotechnology.

23 Sep 2016

Ancient remedy to treat severe diarrhea becomes effective therapy for multiple recurrent CDI

Modern medicine is taking a new look at an ancient remedy for severe diarrhea as a novel approach to treat a serious gastrointestinal infection.

22 Sep 2016

Physical therapist suggests tips to help older adults avoid risks of falling

As the National Council on Aging designates Sept. 22 as National Falls Prevention Day, NYIT Associate Professor Veronica Southard says older adults should be mindful of the risks of falling, but not let their fears take over their lives.

22 Sep 2016

JAK inhibitors may be first effective treatment for people with alopecia areata

Seventy-five percent of patients with moderate to severe alopecia areata—an autoimmune disease that causes patchy, and less frequently, total hair loss—had significant hair regrowth after treatment with ruxolitinib, reported researchers from Columbia University Medical Center. By the end of their treatment, average hair regrowth was 92 percent.

22 Sep 2016

Color-deficiency or color-blindness?

Color blindness could be considered a bit of a misleading term, because there are very few people who can't see color at all. Most people have what we call color deficiency or color confusion, which means that they're not blind to color; they just see a reduced number of colors.

From Vision Express 22 Sep 2016

Study data does not support benefits of testosterone supplementation in men with ‘low T’

The prescription of testosterone supplementation for cardiovascular health, sexual function, physical function, mood, or cognitive function in men with "low T" is not supported by clinical trials data, conclude researchers who describe a review of more than 200 clinical trials published Sept. 21 in PLOS One.

22 Sep 2016

CIRM approves $5.2 million for research on life-long treatment for rare childhood disease

Cystinosis is a rare disease that usually strikes children before they are two years old and can lead to end stage kidney failure before their tenth birthday.

22 Sep 2016

Scientists discover genomic alterations in pediatric relapsed ALL

A group of researchers from Columbia University, Rutgers University, and institutions in Europe and Japan have identified genomic alterations in pediatric relapsed acute lymphoblastic leukemia (ALL) that cause both therapy resistance and improved clinical response to multi-agent chemotherapy treatment.

22 Sep 2016

Duke, Wisconsin and UAB researchers create bioengineered patches to treat heart failure

The heart cannot regenerate muscle tissue after a heart attack has killed part of the muscle wall, and that dead tissue can strain surrounding muscle, leading to a lethal heart enlargement.

22 Sep 2016

Investigators provide data on status of psychosomatic medicine in Germany

In the current issue of Psychotherapy and Psychosomatics a group of German investigators headed by Prof. Stefan Zipfel brings data on the status of psychosomatic medicine in Germany.

22 Sep 2016

Novel immunotherapy shows promise against AML in clinical trial

A new type of immunotherapy shows promise against cases of acute myeloid leukemia (AML) that recur after treatment or that never respond to therapy in the first place.

21 Sep 2016

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Brain metastases are one of the most common complications of advanced melanoma, requiring multidisciplinary management.

21 Sep 2016

Three-dimensional heart patches may soon move closer to clinical application

The promise of stem cells to treat cardiovascular disease may soon be a step closer to clinical application as scientists from three institutions seek to perfect and test three-dimensional "heart patches" in a large animal model — the last big hurdle before trials in human patients.

21 Sep 2016

TSRI scientists shed light on molecular workings of MS drug

A study by scientists at The Scripps Research Institute has helped to de-mystify the molecular workings of the multiple sclerosis (MS) drug Tecfidera. The drug is the most widely prescribed pill-based therapy for MS, but its biological mechanism remains mysterious.

21 Sep 2016

Duke researchers discover blood markers linked to drug-resistant tumor cells

While searching for a non-invasive way to detect prostate cancer cells circulating in blood, Duke Cancer Institute researchers have identified some blood markers associated with tumor resistance to two common hormone therapies.

21 Sep 2016

Scientists engineer smallest-reported synthetic virus that may help advance gene therapy

Gene therapy is a kind of experimental treatment that is designed to fix faulty genetic material and help a patient fight off or recover from a disease.

21 Sep 2016

Therapy News and Research

Mitochondrial alternative oxidase from sea-squirt shows potential to fight against sepsis

Researchers receive grant to help develop stem cell therapy for glaucoma

Precision medicine trial shows analysing person's DNA improves treatment options for cancer patients

Review highlights anxiety may lead to serious health consequences in dialysis patients

Magnetic bacteria can be promising vehicle for efficiently delivering tumor-fighting drugs

Ancient remedy to treat severe diarrhea becomes effective therapy for multiple recurrent CDI

Physical therapist suggests tips to help older adults avoid risks of falling

JAK inhibitors may be first effective treatment for people with alopecia areata

Color-deficiency or color-blindness?

Study data does not support benefits of testosterone supplementation in men with ‘low T’

CIRM approves $5.2 million for research on life-long treatment for rare childhood disease

Scientists discover genomic alterations in pediatric relapsed ALL

Duke, Wisconsin and UAB researchers create bioengineered patches to treat heart failure

Investigators provide data on status of psychosomatic medicine in Germany

Novel immunotherapy shows promise against AML in clinical trial

Immune and targeted therapies may be beneficial in patients with melanoma brain metastases

Three-dimensional heart patches may soon move closer to clinical application

TSRI scientists shed light on molecular workings of MS drug

Duke researchers discover blood markers linked to drug-resistant tumor cells

Scientists engineer smallest-reported synthetic virus that may help advance gene therapy

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News